Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer

Pat Gulhati, Aislyn Schalck, Shan Jiang, Xiaoying Shang, Chang‐Jiun Wu, Pingping Hou, Sharia Hernández Ruiz, Luisa M. Solis Soto, Edwin R. Parra, Haoqiang Ying, Jincheng Han, Prasenjit Dey, Jun Li, Pingna Deng, Emi Sei, Dean Y. Maeda, John A. Zebala, Denise J. Spring, Michael P. Kim, Huamin Wang, Anirban Maitra, Dirk F. Moore, Karen Clise-Dwyer, Yanru Wang, Nicholas E. Navin, Ronald A. DePinho